|
Boston Bio Systems Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
5.20 Cr.
|
P/BV
|
0.81
|
Book Value (Rs.)
|
9.21
|
|
52 Week High/Low (Rs.)
|
22/7
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Diluted EPS (Rs.) | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (Rs.) | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 9.21 | 9.41 | 9.43 | 9.42 | 9.42 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 9.21 | 9.41 | 9.43 | 9.42 | 9.42 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.00 | 0.99 | 0.69 | 2.14 |
| PBDIT / Share (Rs.) | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIT / Share (Rs.) | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBT / Share (Rs.) | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit / Share (Rs.) | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 0.00 | 0.00 | 0.07 | 0.31 | 0.06 |
| PBIT Margin (%) | 0.00 | 0.00 | 0.07 | 0.19 | 0.02 |
| PBT Margin (%) | 0.00 | 0.00 | 0.05 | 0.15 | 0.02 |
| Net Profit Margin (%) | 0.00 | 0.00 | 0.04 | 0.10 | 0.01 |
| Return on Networth / Equity (%) | -2.18 | -0.03 | 0.00 | 0.00 | 0.00 |
| Return on Capital Employeed (%) | -2.14 | -0.03 | 0.00 | 0.01 | 0.00 |
| Return On Assets (%) | -1.33 | -0.02 | 0.00 | 0.00 | 0.00 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 6.94 | 5.20 | 16.75 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.19 | 1.24 | 1.27 | 1.37 | 1.44 |
| Quick Ratio (X) | 1.16 | 1.20 | 1.27 | 1.37 | 1.44 |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 43.66 | 0.00 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 0.00 | 0.00 | 3.18 | 5.70 | 0.00 |
| Interest Coverage Ratio (Post Tax) (%) | 0.00 | 0.00 | 3.11 | 4.25 | 0.00 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 12.55 | 12.55 | 12.54 | 12.59 | 12.57 |
| EV / Net Operating Revenue (X) | 0.00 | 0.00 | 17.92 | 25.84 | 8.40 |
| EV / EBITDA (X) | -89.19 | -5704.18 | 23933.98 | 8100.65 | 12360.05 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 0.00 | 16.77 | 24.08 | 7.84 |
| Price / BV (X) | 1.82 | 1.78 | 1.78 | 1.78 | 1.78 |
| Price / Net Operating Revenue (X) | 0.00 | 0.00 | 16.78 | 24.12 | 7.85 |
| EarningsYield | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
